Search Results

There are 8650 results for: content related to: Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy

  1. You have free access to this content
    Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy


    Volume 119, Issue 16, 15 August 2013, Pages: 3012–3019, Matthew D. Galsky, Erin Moshier, Susan Krege, Chia-Chi Lin, Noah Hahn, Thorsten Ecke, Guru Sonpavde, James Godbold, William K. Oh and Aristotle Bamias

    Version of Record online : 29 MAY 2013, DOI: 10.1002/cncr.28146

  2. You have free access to this content
    Tools to improve clinical trial design in urothelial cancer


    Volume 119, Issue 16, 15 August 2013, Pages: 2950–2952, Allison M. Deal and Matthew I. Milowsky

    Version of Record online : 29 MAY 2013, DOI: 10.1002/cncr.28176

  3. You have free access to this content
    Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer


    Volume 121, Issue 15, August 1, 2015, Pages: 2586–2593, Matthew D. Galsky, Sumanta K. Pal, Simon Chowdhury, Lauren C. Harshman, Simon J. Crabb, Yu-Ning Wong, Evan Y. Yu, Thomas Powles, Erin L. Moshier, Sylvain Ladoire, Syed A. Hussain, Neeraj Agarwal, Ulka N. Vaishampayan, Federica Recine, Dominik Berthold, Andrea Necchi, Christine Theodore, Matthew I. Milowsky, Joaquim Bellmunt, Jonathan E. Rosenberg and for the Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators

    Version of Record online : 14 APR 2015, DOI: 10.1002/cncr.29387

  4. You have free access to this content
    Use of the lung cancer–specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development


    Volume 121, Issue 24, December 15, 2015, Pages: 4300–4323, Michael Koller, Sophie Warncke, Marianne J. Hjermstad, Juan Arraras, Cecilia Pompili, Amelie Harle, Colin D. Johnson, Wei-Chu Chie, Christian Schulz, Florian Zeman, Jan P. van Meerbeeck, Dagmara Kuliś, Andrew Bottomley and on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group and the EORTC Lung Cancer Group

    Version of Record online : 9 OCT 2015, DOI: 10.1002/cncr.29682

  5. You have free access to this content
    Chemotherapy for advanced non-small cell lung cancer in the elderly population

    Intervention Review

    The Cochrane Library

    Fábio N Santos, Tiago B de Castria, Marcelo RS Cruz and Rachel Riera

    Published Online : 20 OCT 2015, DOI: 10.1002/14651858.CD010463.pub2

  6. You have free access to this content
    Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review

    International Journal of Urology

    Volume 21, Issue 7, July 2014, Pages: 630–637, Terence T Sio, Jocelyn Ko, Vinay K Gudena, Nitin Verma and Uzair B Chaudhary

    Version of Record online : 23 JAN 2014, DOI: 10.1111/iju.12407

  7. Bladder Cancer: Current Management and Opportunities for a Personalized Approach

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 587–596, Matthew D. Galsky and Simon J. Hall

    Version of Record online : 23 NOV 2010, DOI: 10.1002/msj.20224

  8. You have free access to this content
    A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma


    Volume 120, Issue 17, September 1, 2014, Pages: 2684–2693, Maha Hussain, Stephanie Daignault, Neeraj Agarwal, Petros D. Grivas, Arlene O. Siefker-Radtke, Igor Puzanov, Gary R. MacVicar, Ellis Glenn Levine, Sandy Srinivas, Przemyslaw Twardowski, Mario A. Eisenberger, David I. Quinn, Ulka N. Vaishampayan, Evan Y. Yu, Scott Dawsey, Kathleen C. Day, Mark L. Day, Mahmoud Al-Hawary and David C. Smith

    Version of Record online : 6 MAY 2014, DOI: 10.1002/cncr.28767

  9. You have free access to this content
    Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options


    Volume 120, Issue 6, 15 March 2014, Pages: 781–789, Sanjiv S. Agarwala, Alexander M. M. Eggermont, Steven O'Day and Jonathan S. Zager

    Version of Record online : 2 DEC 2013, DOI: 10.1002/cncr.28480

  10. You have free access to this content
    Multidisciplinary approaches to intrahepatic cholangiocarcinoma


    Volume 119, Issue 22, 15 November 2013, Pages: 3929–3942, Shishir K. Maithel, T. Clark Gamblin, Ihab Kamel, Celia Pamela Corona-Villalobos, Melanie Thomas and Timothy M. Pawlik

    Version of Record online : 20 AUG 2013, DOI: 10.1002/cncr.28312

  11. You have free access to this content
    Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma


    Volume 120, Issue 5, 1 March 2014, Pages: 692–701, Petros D. Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler, Robert Dreicer, Manish Kohli, Daniel P. Petrylak, David J. Vaughn, Kathryn A. Bylow, Steven G. Wong, Joseph L. Sottnik, Evan T. Keller, Mahmoud Al-Hawary, David C. Smith and Maha Hussain

    Version of Record online : 18 NOV 2013, DOI: 10.1002/cncr.28477

  12. You have free access to this content
    Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non–small cell lung cancer


    Volume 119, Issue 11, 1 June 2013, Pages: 2048–2060, Junya Zhu, Dhruv B. Sharma, Aileen B. Chen, Bruce E. Johnson, Jane C. Weeks and Deborah Schrag

    Version of Record online : 5 APR 2013, DOI: 10.1002/cncr.28022

  13. Current management and future directions in metastatic pancreatic adenocarcinoma


    Volume 122, Issue 24, December 15, 2016, Pages: 3765–3775, Anna M. Varghese, Maeve A. Lowery, Kenneth H. Yu and Eileen M. O'Reilly

    Version of Record online : 20 SEP 2016, DOI: 10.1002/cncr.30342

  14. You have free access to this content
    Novel agents for muscle-invasive and advanced urothelial cancer

    BJU International

    Volume 101, Issue 8, April 2008, Pages: 937–943, Guru Sonpavde, Robert Ross, Thomas Powles, Christopher J. Sweeney, Noah Hahn, Thomas E. Hutson, Matthew D. Galsky, Seth P. Lerner and Cora N. Sternberg

    Version of Record online : 13 NOV 2007, DOI: 10.1111/j.1464-410X.2007.07326.x

  15. You have full text access to this OnlineOpen article
    Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer

    Cancer Medicine

    Volume 4, Issue 8, August 2015, Pages: 1224–1239, Neelam V. Desai, Sarunas Sliesoraitis, Steven J. Hughes, Jose G. Trevino, Robert A. Zlotecki, Alison M. Ivey and Thomas J George Jr

    Version of Record online : 13 MAR 2015, DOI: 10.1002/cam4.444

  16. You have free access to this content
    Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab


    Volume 120, Issue 12, 15 June 2014, Pages: 1780–1786, Shubham Pant, Ludmila K. Martin, Susan Geyer, Lai Wei, Katherine Van Loon, Nilli Sommovilla, Mark Zalupski, Renuka Iyer, David Fogelman, Andrew H. Ko and Tanios Bekaii-Saab

    Version of Record online : 13 MAR 2014, DOI: 10.1002/cncr.28648

  17. You have full text access to this OnlineOpen article
    Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma


    Volume 121, Issue 7, April 1, 2015, Pages: 1128–1137, Joseph M. Herman, Daniel T. Chang, Karyn A. Goodman, Avani S. Dholakia, Siva P. Raman, Amy Hacker-Prietz, Christine A. Iacobuzio-Donahue, Mary E. Griffith, Timothy M. Pawlik, Jonathan S. Pai, Eileen O'Reilly, George A. Fisher, Aaron T. Wild, Lauren M. Rosati, Lei Zheng, Christopher L. Wolfgang, Daniel A. Laheru, Laurie A. Columbo, Elizabeth A. Sugar and Albert C. Koong

    Version of Record online : 23 DEC 2014, DOI: 10.1002/cncr.29161

  18. You have free access to this content
    Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice


    Volume 121, Issue 19, October 1, 2015, Pages: 3428–3434, Anne-Sophie Dussol, Marie-Odile Joly, Cecile Vercherat, Julien Forestier, Valérie Hervieu, Jean-Yves Scoazec, Catherine Lombard-Bohas and Thomas Walter

    Version of Record online : 8 JUN 2015, DOI: 10.1002/cncr.29517

  19. You have free access to this content
    A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma

    BJU International

    Volume 113, Issue 5b, May 2014, Pages: E137–E143, Gregory R. Pond, Neeraj Agarwal, Joaquim Bellmunt, Toni K. Choueiri, Angela Qu, Ronan Fougeray, David Vaughn, Nicholas D. James, Yacine Salhi, Peter Albers, Günter Niegisch, Matthew D. Galsky, Yu-Ning Wong, Yoo-Joung Ko, Walter M. Stadler, Peter H. O'Donnell, Srikala S. Sridhar, Nicholas J. Vogelzang, Andrea Necchi, Giuseppe Di Lorenzo, Cora N. Sternberg, Amitkumar Mehta and Guru Sonpavde

    Version of Record online : 23 APR 2014, DOI: 10.1111/bju.12564

  20. Guidelines for chemotherapy of biliary tract and ampullary carcinomas

    Journal of Hepato-Biliary-Pancreatic Surgery

    Volume 15, Issue 1, January 2008, Pages: 55–62, Junji Furuse, Tadahiro Takada, Masaru Miyazaki, Shuichi Miyakawa, Kazuhiro Tsukada, Masato Nagino, Satoshi Kondo, Hiroya Saito, Toshio Tsuyuguchi, Koichi Hirata, Fumio Kimura, Hideyuki Yoshitomi, Satoshi Nozawa, Masahiro Yoshida, Keita Wada, Hodaka Amano and Fumihiko Miura

    Version of Record online : 16 FEB 2008, DOI: 10.1007/s00534-007-1280-z